KemNet
KemNet supplies reformulated drugs for specific groups of patients.
ActiveSummer 2022Marketplace
About KemNet
KemNet supplies reformulated drugs for specific groups of patients.
Risk Analysis
Category Risk
27%death rate
Marketplace: 60 of 221 startups failed
MEDIUMTeam Size
2people
Median for failed in Marketplace: 4
Median for active in Marketplace: 13.5
External Resources
Read full post-mortem on startups.rip ↗(opens in new tab)Website ↗(opens in new tab)YC Profile ↗(opens in new tab)Report data issue
Post-mortem content hosted on startups.rip — we provide the analytics layer.